Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
SWEAT fluctuated by 269.9% in 24 hours: Surging trading volume under low liquidity triggers extreme price volatility

SWEAT fluctuated by 269.9% in 24 hours: Surging trading volume under low liquidity triggers extreme price volatility

Bitget PulseBitget Pulse2026/05/09 15:27
Show original
By:Bitget Pulse

Volatility Overview

In the past 24 hours, the price of SWEAT surged from a low of $0.0001822 to a high of $0.0006739, with the current quote at $0.000454, reflecting an amplitude of 269.9% and displaying an intense fluctuation pattern. Trading volume skyrocketed to approximately $2.91 million (about a 300% increase from the previous day), with a market capitalization around $4.23 million and a Vol/Mkt Cap ratio as high as 64%, indicating a high turnover rate.

Brief Analysis of the Reasons for the Move

- Combination of Low Liquidity and Surging Volume: As a low market cap token (circulating market cap about $4 million), SWEAT's 24-hour trading volume soared to $2.9 million, resulting in extreme price volatility, directly driving the 269.9% amplitude from low to high.

- No clear official announcement, large on-chain whale transfers, or major news events within the past 24 hours; the move is purely a result of volume and price resonance amid insufficient market liquidity.

Market Perspectives and Outlook

The mainstream market views this move as a typical “wick” fluctuation of low-liquidity, small-cap coin. Traders are focusing on whether trading momentum will continue (some observers such as Coinugget noted a momentum collapse after the high, which could lead to further declines or a rapid rebound). Community discussions are limited, with no significant FOMO sentiment, and analysts caution that risks remain high due to low liquidity. Short-term volatility may persist, and further selling pressure should be watched out for.

Note: This analysis is automatically generated by AI based on public data and on-chain monitoring, for informational purposes only.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Marvell Technology (MRVL.US) plummets after earnings: Beating forecasts is not enough—Wall Street thinks Google (GOOGL.US) orders are recognized too slowly

Although Marvell Technology's latest financial report and future revenue guidance both superficially exceeded market expectations, its stock price still plummeted in pre-market trading on Friday.

智通财经2026/08/28 12:56
Marvell Technology (MRVL.US) plummets after earnings: Beating forecasts is not enough—Wall Street thinks Google (GOOGL.US) orders are recognized too slowly

From Lowering Blood Sugar and Weight Loss to Cardiovascular Protection! Mounjaro Achieves "Cardiometabolic Leap," Lilly (LLY.US) Opens GLP-1's Second Growth Curve

Eli Lilly's diabetes drug Mounjaro has received approval in the United States for reducing the risk of serious cardiovascular disease. The U.S. Food and Drug Administration has approved Mounjaro for lowering cardiovascular risk in adults with type 2 diabetes who have established heart disease.

智通财经2026/08/28 12:36
From Lowering Blood Sugar and Weight Loss to Cardiovascular Protection! Mounjaro Achieves "Cardiometabolic Leap," Lilly (LLY.US) Opens GLP-1's Second Growth Curve